Sugatani et al., "In vitro Actions Of Some Antibiotics On Phospholipases", J. of Antibiotics 32: 734-739 (1979). |
Pruzanski et al., "Phospholipase A.sub.2 --A Mediator Between Proximal And Distal Effectors Of Inflammation", Immuno. Today 12: 143-146 (1991). |
Granstrom, "The Arachidonic Acid Cascade", Inflammation 8: S15-25 (1984, suppl 5). |
O'Flaherty, "Lipid Mediators Of Inflammation And Allergy", Lab. Invest. 47: 314-329 (1982). |
Trang, "Prostaglandins And Inflammation", Sem. Arthritis Rheum. 9: 153-190 (1980). |
Williams, "Interactions Between Prostaglandins, Leukotrienes And Other Mediators Of Inflammation", Br. Med. Bull. 39: 239-242 (1983). |
Van den Bosch, "Intracellular Phospholipases A", Biochem.Biophys. Acta 604: 191-246 (1980). |
Vadas et al., "Role Of Secretory Phospholipases A.sub.2 In The Pathobiology Of Disease", Lab. Invest. 55: 391-404 (1986). |
Mizel, "The Interleukins", FASEB J. 3: 2379-2388 (1989). |
Beutler et al., "Cachectin: More Than A Tumor Necrosis Factor", New Engl. J. Med. 316: 379-385 (1987). |
Nathan et al., "Cytokines: Interferon-.gamma.", in Inflammation (Gallin et al. eds.) Raven Press 229-251 (1988). |
Braquet et al., "Platelet-Activating Factor And Cellular Immune Responses", Immunol Today 8: 345-352 (1987). |
Marcus, "Eicosanoids: Transcellular Metabolism", in Inflammation (Gallin et al. eds.) Raven Press 129-137 (1988). |
Wolpe et al., "Macrophage Inflammatory Proteins 1 And 2: Members Of A Novel Superfamily Of Cytokines", FASEB J.3: 2565-2573 (1989). |
Hsueh et al., "Two Phospholipase Pools For Prostaglandin Synthesis In Macrophages", Nature 290: 710-713 (1981). |
Franson et al., "Isolation And Characterization Of A Phospholipase A.sub.2 From An Inflammatory Exudate", J.LipidRes. 19: 18-23 (1978). |
Gans et al., "Extracellular Phospholipase A.sub.2 Activity In Cell Free Peritoneal Lavage Fluid From Mice With Zymosan Peritonitis", Agents & Actions 27: 341-343 (1989). |
Vadas et al., "Involvement Of Circulating Phospholipase A.sub.2 In The Pathogenesis Of The Hemodynamic Changes In Endotoxin Shock", Can. J. Physiol. Pharmacol. 61: 561-566 (1983). |
Marsh et al., "The Effects Of Honey Bee (Apis mellifera L.) Venom And Two Of Its Constituents, Melittin And Phospholipase A.sub.2 On The Cardiovascular System Of The Rat", Toxicon. 18: 427-435 (1980). |
Huang et al., "Relaxant Effect Of Phospholipase A.sub.2 From Vipera russelli Snake Venom On Rat Aorta", Eur.J.Pharmacol. 118: 139-146 (1985). |
Morgan et al., "Phospholipids, Acute Pancreatitis, And The Lungs: Effect Of Lecithinase Infusion On Pulmonary Surface Activity In Dogs", Ann. Surg. 167: 329-335 (1968). |
Stommer et al., "Phospholipase A.sub.2 Induced Diffuse Aleolar Damage--Effect Of Indomethacin And Dexamethasone Upon Morphology And Plasma-Histamine Level", Klin.Wochenschr. 67: 171-176 (1989). |
Shaw et al., "Phospholipase A.sub.2 Contamination Of Cobra Venom Factor Preparations", Am. J. Pathol. 91: 517-530 (1978). |
Vadas et al., "Extracellular Phospholipase A.sub.2 Mediates Inflammatory Hyperaemia", Nature 293: 583-585 (1981). |
Pruzanski et al., "Inflammatory Effect Of Intradermal Administration Of Soluble Phospholipase A.sub.2 In Rabbits", J.Invest. Dermatol. 86, 380-383 (1986). |
Vadas et al., "The Proinflammatory Effect Of Intra-Articular Injection Of Soluble Human And Venom Phospholipase A.sub.2 ", Am. J. Pathol. 134: 807-811 (1989). |
Vishwanath et al., "Edema-Inducing Activity Of Phospholipase A.sub.2 Purified From Human Synovial Fluid And Inhibition By Aristolochic Acid", Inflammation 12: 549-561 (1988). |
Cirino et al., "A Study Of Phospholipase A.sub.2 -Induced Oedema In Rat Paw", Eur. J. Pharmacol. 166: 505-510 (1989). |
Pruzanski et al., "Phospholipase A.sub.2 Activity In Sera And Synovial Fluids In Rheumatoid Arthritis And Osteoarthritis. Its Possible Role As A Proinflammatory Enzyme", J. Rheumatol. 12: 211-216 (1985). |
Vadas et al., "Phospholipases A.sub.2 In Acute Bacterial Peritonitis In Man", in Cell Activation and Signal Initiation (Dennis et al., eds.) Alan R. Liss 311-316 (1989). |
Vadas et al., "Pathogenesis Of Hypotension In Septic Shock: Correlation Of Circulating Phospholipase A.sub.2 Levels With Circulatory Collapse", Crit. Care Med. 16: 1-7 (1988). |
Vadas, "Elevated Plasma Phospholipase A.sub.2 Levels: Correlation With The Hemodynamic And Pulmonary Changes In Gram-Negative Septic Shock", J. Lab. Clin. Med. 104: 873-881 (1984). |
Jakobsen, et al., "Demonstration Of Soluble Plasmodium falciparum Antigens Reactive With Limulus Amoebocyte Lysate And Polymyxin B", Parasite Immunol. 10: 593-606 (1988). |
Clark, "Does Endotoxin Cause Both The Disease And Parasite Death In Acute Malaria And Babesiosis?", Lancetii: 75-77 (1978). |
Ehrlich, "Erosive Inflammatory And Primary Generalized Osteoarthritis", in Osteoarthritis, Diagnosis and Management (Moskowitz et al., eds.) W.B. Saunders Co. 199-209 (1984). |
Revell et al., "The Synovial Membrane In Osteoarthritis: A Histological Study Including The Characterisation Of The Cellular Infiltrate Present In Inflammatory Osteoarthritis Using Monoclonal Antibodies", Ann. Rheum. Dis. 47: 300-307 (1988). |
Pelletier et al., "Evidence For The Involvement Of Interleukin 1 In Human Osteoarthritic Cartilage Degradation: Protective Effect Of NSAID", J. Rheumatol. 16: (Suppl. 18) 19-27 (1989). |
Shinmei et al., "The Role Of Cytokines In Chondrocyte Mediated Cartilage Degradation", J. Rheumatol. 16: (Suppl. 18) 32-34 (1989). |
Mitscher, "Chemical Transformations Of The Tetracycline Family", in The Chemistry of Tetracyclines, Chapter 6, Marcel Dekker, Publishers, N.Y. (1978). |
Golub et al., "Further Evidence That Tetracyclines Inhibit Collagenase Activity In Human Crevicular Fluid And Form Other Mammalian Sources", J. Periodont. Res. 20: 12-23 (1985). |
Golub et al., "Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications For An Old Family Of Drugs", Crit. Revs. Oral Biol. & Med. 2: 297-322 (1991). |
Vadas, et al., "Inhibition Of Synovial Fluid Phospholipase A.sub.2 Activity By Two Tetracycline Derivatives, Minocycline And Coxycycline" Arthritis and Rheumatism, 34 Supp. 9: p. S160 (abst C167) (1991). |
Vadas, et al., "Extracellular Phospholipase A.sub.2 Secretion Is A Common Effector Pathway Of Interleukin-1 And Tumor Necrosis Factor Action" Immunol. Letters, 28: 187-194 (1991). |
Breedveld, "Minocycline Treatment For Rheumatoid Arthritis: An Open Dose Finding Study", J. Rheumat. 17: 43-46 (1990). |
Wong et al., "Oral Ibuprofen And Tetracycline For The Treatment Of Acne Vulgaris", Journal of American Academy of Dermatology 11: 1076-1081 (1984). |
Funt, "Oral Ibuprofen And Minocycline For The Treatment Of Resistant Acne Vulgaris", Journal of the American Academy of Dermatology 13: 524-525 (1985). |
Breedveld, "Suppression Of Collagen And Adjuvant Arthritis By A Tetracycline," Northeastern Regional Meeting Of The Amer. Rheum. Assoc., Atlantic City, New Jersey, Oct. 23-24, 1987. |
Skinner et al., "Tetracycline In The Treatment Of Rheumatoid Arthritis", Arthritis And Rheumatism 14; 727-732 (1971). |
Greenwald et al., "Tetracyclines Inhibit Human Synovial Collagenase In Vivo and In Vitro", J. Rheumatol. 14: 28-32 (1987). |
Golub et al., "Tetracyclines (TCs) Inhibit Matrix Metalloproteinases (MMPs): In Vivo Effects In Arthritic And Diabetic Rats, And New In Vitro Studies," Matrix, Suppl. No. 1: 315-316 (1992). |
Sipos et al., "The Effect Of Collagenase Inhibitors On Alveolar Bone Loss Due To Periodontal Disease In Desalivated Rats," abstract presented at Matrix Metalloproteinase Conference, Destin, Florida, Sep. 11-15, (1989). |
Greenwald et al. "CMT, A Metalloproteinase Inhibitor, Prevents Bone Resorption In Adjuvant Arthritis." Arthritis Rheum. 34 (#9 suppl): S66 (abstract #A6), abstract presented at 55th Annual Meeting, Amer. College of Rheumatology, Boston MA, Nov. 18, (1991). |
"Tetracyclines Suppress Matrix Metalloproteinase Activity in Adjuvant Arthritis and in Combination with Flurbiprofen, Ameliorate Bone Damage," Journal of Rheumatology 19, 927-938 (1992). |